Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Tom Powles
Sep 17, 2024, 16:42 |
Blog
Tom Powles: SUNNIFORCAST at ESMO24
Tom Powles shared a post on X: "SUNNIFORCAST at ESMO24 ipi/nivo vs VEGF based therapy…
Sep 14, 2024, 15:38 |
Insight
ESMO24 Day 1 highlights by Tom Powles
The ESMO Congress 2024 (ESMO24) is taking place from 13-17 September 2024, in Barcelona. ESMO24…
Sep 10, 2024, 14:54 |
Blog
Tom Powles: Belzutifan for clear cell renal cancer
Tom Powles shared a post on X: “Belzutifan significantly outperformed Everolimus in heavily pretreated clear…
Sep 9, 2024, 14:16 |
Blog
Tom Powles: Should Enfortumab Vedotin with Pembrolizumab be avoided due to baseline clinical conditions
Tom Powles shared a post on X, about recent paper published in ESMO Open: The…
Aug 26, 2024, 20:08 |
Insight
Tom Powles: Belzutifan significantly outperformed Everolimus in heavily pretreated clear cell renal cancer
Tom Powles, Professor of urology cancer at the University of London and the Director of…
Aug 14, 2024, 12:07 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Tom Powles
We are excited to spotlight Dr. Tom Powles, a leading expert in urological oncology, as…
Jul 21, 2024, 09:13 |
Insight
Sumanta K. Pal: Excellent review on kidney cancer from Tom Powles
Sumanta K. Pal shared on X a recent paper by Matthew Young et al. titled…
Jul 20, 2024, 18:07 |
Blog
Tom Powles: More evidence that PD(L)1 re-challenge should be avoided in renal cancer
Tom Powles posted on X/Twitter: "More evidence that PD(L)1 re-challenge should be avoided in renal…
Jul 7, 2024, 14:06 |
Blog
Christian Gratzke: Great to have Tom Powles at Uro Trials
Christian Gratzke, Urologic Surgeon and Chair at University of Freiburg, shared on X: "Great to have…
Jul 6, 2024, 08:45 |
Insight
Tom Powles on RCC patients receiving ICI therapy
Tom Powles shared on X: “During the period of PD-1 inhibition availability for RCC in…
1
2
3
4
5
All:
91
Posts:
1 - 10
43 Posts Not To Miss From ESMO24 Day 2
45 Posts not to miss from ESMO24 Day 1
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube